Normal Ventilatory and Perfusion Pulmonary Function in TEMP
NCT ID: NCT04332406
Last Updated: 2020-04-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
96 participants
OBSERVATIONAL
2019-06-13
2019-10-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In that context, it would be of interest to build statistical maps from registrered normal studies and propose a new methodology for normal SPECT delineation
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Optimization of Arterial Oxygen Transport by Positive End-expiratory Pressure Variation in Acute Respiratory Distress Syndrome
NCT01256333
Effects of Different I:E Ratio on Intrapulmonary Shunt Fraction and Oxygenation During One Lung Ventilation in the Lateral Decubitus Position
NCT01499212
The Change of Pulmonary Blood Flow During One Lung Ventilation
NCT00826956
The Effect of High Frequency Percussive Ventilation on Cerebral Tissue Oxygenation
NCT02545803
Comparison of Esophageal and Central Venous Pressure for Estimating Transpulmonary Pressure Changes
NCT04443491
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* confirmation by a second senior physician
Exclusion Criteria
* chronic obstruction pulmonary disease,
* previous pulmonary embolism,
* surgery of the lungs
* radiotherapy of the lungs
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Brest
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pierre Yves Le Roux, MD, Phd
Role: STUDY_DIRECTOR
CHRU Brest
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Médecine nucléaire - Hôpital Morvan (CHRU de Brest)
Brest, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
29BRC19.0129
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.